Skip to content

A Study for Evaluating the Effects of test food Intake on Hormones and Related Parameters - single-arm open-label study-

A Study for Evaluating the Effects of test food Intake on Hormones and Related Parameters - single-arm open-label study- - A Study for Evaluating the Effects of test food Intake on Hormones and Related Parameters - single-arm open-label study-

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059997
Enrollment
13
Registered
2025-12-05
Start date
2025-12-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

Daily consumption of the test food over 12 weeks.

Sponsors

APO PLUS STATION CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy Japanese males aged 40 years old or older but under 65 at the time of consent. (2) Individuals who report subjective symptoms such as fatigue, lethargy, lack of energy, or decreased libido. (3) Individuals who have results from a health examination conducted within the past year and show no abnormalities requiring treatment. (4) Individuals who have received sufficient explanation about the study and have signed the informed consent form prior to the study initiation.

Exclusion criteria

Exclusion criteria: (1) Individuals who are currently undergoing treatment for, or have a history of, malignant tumors, heart failure, or myocardial infarction. (2) Individuals currently receiving treatment for, or with a history of, the following conditions: [1] Arrhythmia, liver dysfunction, renal impairment, cerebrovascular disease, thyroid disorders, rheumatoid arthritis, diabetes, dyslipidemia, hypertension, or other chronic illnesses. [2] Conditions requiring hormone therapy. (3) Individuals currently undergoing treatment for, or with a history of, drug or alcohol dependence. (4) Individuals diagnosed with male infertility. (5) Individuals with mental disorders, depressive symptoms, or currently receiving treatment for such conditions. (6) Individuals with food allergies or those who may have allergic reaction to test food. (7) Individuals who regularly use prescription drugs or quasi-drugs that may affect the study outcomes and are unable to discontinue their use during the study period. (8) Individuals who regularly consume health foods that may affect the study outcomes and are unable to discontinue their use during the study period. (9) Individuals who consume excessive amounts of alcohol. (10) Individuals with heavy smoking habits. (11) Individuals unable to abstain from alcohol and smoking from the day before each visit until the end of the examination. (12) Individuals who may be unable to maintain their usual lifestyle. (13) Individuals with extremely irregular lifestyle habits, such as night shift workers. (14) Individuals planning to travel abroad during the study period. (15) Individuals who participated in another clinical trial within one month prior to the date of consent, or plan to participate in another clinical trial during the study period. (16) Individuals deemed inappropriate for participation by the principal investigator.

Design outcomes

Primary

MeasureTime frame
Testosterone levels

Secondary

MeasureTime frame
1) PSQI-J 2) JAMQ 3) Likert-Type Scale

Countries

Japan

Contacts

Public ContactMasako Mizuuchi

APO PLUS STATION CO., LTD. Clinical Operations Dept., CRO Business div.

food-contact@apoplus.co.jp03-6777-7789

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026